Lung function after SARS‐CoV‐2 infection: A prospective cohort study in children
Authors:
- Elio IovineEIElio Iovine
- Raffaella NennaRNRaffaella Nenna
- Domenico Paolo La ReginaDRDomenico Paolo La Regina
- Laura PetrarcaLPLaura Petrarca
- Fabio MidullaFabio Midulla
- on behalf of the Long COVID Research GroupOGon behalf of the Long COVID Research Group
Open Access
- 21 April 2023
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 58 (7) , 2009-2016
Abstract
Introduction: Although impaired lung function after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been described in adults, it is unclear whether lung function might be altered in children, especially among asymptomatic or mildly symptomatic patients. In this study, we report the results of lung function testing performed after SARS‐CoV‐2 infection in a large pediatric population.Methods: The study included 589 patients with previous confirmed SARS‐CoV‐2 infection aged 0–18 years. Both symptomatic and asymptomatic patients during acute infection were enrolled in the study. A spirometry was performed in all cooperating patients.Results: The mean age of enrolled patients was 9.6 years and the mean time from infection to enrollment was 171 days. Spirometry was performed and deemed evaluable in 433 patients. No patient had reduced forced vital capacity (FVC) and only 14 patients (3.2%) had a forced expiratory volume in the First second (FEV1) < 80%. The mean spirometry values recorded were in the normal range. There were no statistically significant differences in spirometry values between patients with respiratory symptoms during infection and those without. Similarly, there were no differences in spirometry parameters according to the time elapsed between infection and enrollment.Conclusion: Lung function, according to spirometry values, does not appear to be impaired long after infection in the pediatric population. The presence of respiratory symptoms during SARS‐CoV‐2 infection would not represent a risk factor for impaired lung function in this cohort of patients.Keywords
This publication has 27 references indexed in Scilit:
- A minimal common outcome measure set for COVID-19 clinical researchThe Lancet Infectious Diseases, 2020
- Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort studyThe Lancet Infectious Diseases, 2020
- Children with Covid-19 in Pediatric Emergency Departments in ItalyNew England Journal of Medicine, 2020
- Abnormal pulmonary function in COVID-19 patients at time of hospital dischargeEuropean Respiratory Journal, 2020
- Inhaled corticosteroids and COVID-19: a systematic review and clinical perspectiveEuropean Respiratory Journal, 2020
- SARS-CoV-2 Infection in ChildrenNew England Journal of Medicine, 2020
- Will children reveal their secret? The coronavirus dilemmaEuropean Respiratory Journal, 2020
- Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical StatementAmerican Journal of Respiratory and Critical Care Medicine, 2019
- National and regional asthma programmes in EuropeEuropean Respiratory Review, 2015
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEuropean Respiratory Journal, 2012